Invion Ltd has released a press release.
Appendix 4C - March 2020 quarter
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- App 4D and Financial Report for half year to 31 Dec 2019
- Invion signs R&D Services Agreement with Pavay Biotech
- Appendix 4C - December 2019 quarter
- Additional Information to Prior Announcement
- Pre-clinical research agreement with Peter MacCallum CC
Later from Invion
- Invion subsidiary signs Supply Agreement with Pavay Biotech
- Activities Report and Appendix 4C June 2020 Quarter
- Business Update and Change to Board and Management
- App 4D and Financial Report for half year to 31 Dec 2020
- Initial Proof-of-Concept results show INV043 to be effective
Follow Invion into a list and get an email when it puts out news.
Follow Invion